Overexpression of Rififylin is a Genetically Determined Risk Factor Linked to Aberrant Cardiomyocyte Function, QT Interval and Hypertension Meeting Abstract (Web of Science)

cited authors

Gopalakrishnan, Kathirvel; Morgan, Eric; Kumarasamy, Sivarajan; Yerga-Woolwine, Shane; Farms, Phyllis; Kalinoski, Andrea; Liu, Lijun; Joe, Bina

authors

publication date

November 1, 2010

webpage

Web of Science

published in

HYPERTENSION Journal

category

PERIPHERAL VASCULAR DISEASE Category

start page

E94

end page

E94

volume

56

issue

5